
CBRE · NYSE
The consensus is Buy, with all eight tracked analysts supporting that rating. The only stated target statistic is a mean of $180; both the low and high targets are unavailable, so the target spread cannot be quantified. No named analyst or firm is identified as most or least bullish, and the supplied evidence contains no rating or target revisions during the past week. The substantive disagreement behind the target dispersion therefore cannot be established from the material provided. The available research instead centers on CBRE’s second-quarter momentum: 30% Core EPS growth, 16% revenue growth, and double-digit expansion in both resilient and transactional businesses.